- UAE-based Valeo Health raises $12 million in a Series B funding round, bringing its total funding to $20 million
- The round was led by Flintera, with participation from existing and new investors including Nuwa Capital, FJ Labs, Oryx, Mindshift Capital, Oraseya, and Eirad.
- Funds will support AI technology expansion, product development, and market reach across Saudi Arabia, the UAE, and the GCC.
Valeo Health, a UAE-based healthtech company specializing in personalized, AI-driven healthcare services, has secured $12 million in a Series B funding round, bringing its total funding to $20 million since inception.
The round was led by Flintera, with continued support from existing investors Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital. New investors Oraseya and Eirad also joined the round, reflecting growing confidence in the company’s vision and regional impact.
Founded in 2021 by Sundeep Sahni, Nadine Karadag, and Ankur Majumder, Valeo Health is reshaping healthcare in the GCC through advanced AI technologies. The company offers a suite of solutions including at-home care, personalized treatment plans, and tech-enabled diagnostics, all designed to make healthcare more accessible, data-driven, and patient-centric.
العربية (Arabic) To read the article in Arabic, click here
